Arcturus Therapeutics Funding & Investors

Arcturus Therapeutics Holdings Inc. operates as a holding company. The company, through its subsidiaries, focuses on RNA therapeutics for the treatment of diseases. Arcturus Therapeutics Holdings serves patients in the United States.

Total Amount Raised: $489,580,064

Arcturus Therapeutics Funding Rounds

Grant
$9,000,000
Sep 25, 2023
Grant Investors
Cystic Fibrosis Foundation
Grant
$115,000,000
Aug 13, 2023
Grant Investors
Government of Japan
Grant
$63,200,000
Aug 30, 2022
Grant Investors
Biomedical Advanced Research and Development Authority
Post Ipo Equity
$200,000,000
Jul 27, 2020
Post Ipo Equity
$80,500,049
Apr 14, 2020
Grant
$15,000,000
Jul 31, 2019
Series A
$5,000,000
Oct 20, 2013
Seed
$1,300,000
May 31, 2013
Seed
$580,001
Apr 4, 2013
IPO
Unknown
Jan 1, 2017

Funding info provided by Diffbot.